Cargando…
Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia
Heparin-induced thrombocytopenia (HIT) is an immune adverse reaction to heparin that is associated with life-threatening thrombotic complications. More rarely, HIT may begin after stopping of heparin or after flushes of heparin (autoimmune HIT). Fondaparinux has been proposed as a candidate treatmen...
Autores principales: | Sartori, Michelangelo, Cosmi, Benilde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575369/ https://www.ncbi.nlm.nih.gov/pubmed/33103050 http://dx.doi.org/10.1055/s-0040-1713175 |
Ejemplares similares
-
Heparin-induced thrombocytopenia and COVID-19
por: Sartori, Michelangelo, et al.
Publicado: (2021) -
The Fondaparinux Paradox: Fondaparinux-Related Heparin-induced Thrombocytopenia
por: Vadi, Sonali, et al.
Publicado: (2018) -
Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?
por: Honore, Patrick M., et al.
Publicado: (2016) -
Fondaparinux in heparin‐induced thrombocytopenia: A decade's worth of clinical experience
por: Schindewolf, Marc
Publicado: (2018) -
Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia
por: Ciurzyński, Michał, et al.
Publicado: (2011)